The Science and Development team at ATAI Life Sciences spearheads the research and innovation of groundbreaking therapies to heal mental health disorders. This interdisciplinary team collaborates across chemistry, clinical operations, digital therapeutics, early development, regulatory affairs, and neurobiology to translate cutting-edge scientific research into effective treatments. They are responsible for overseeing the drug development lifecycle, from discovery through regulatory approval, ensuring that each step aligns with high scientific standards and regulatory requirements.
Carrie Bowen
Lead, Scientist Neurobiology
David Keene
Lead, Digital Therapeutics
Glenn Short
Lead, Early Development
Greg Bates
Lead, Regulatory Affairs
Majed Fawaz
Lead, Chemistry, Manufacturing...
Odette Hauke
Associate Director, Regulatory...
Robert Ezzell Jr.
Senior Director, Regulatory Af...
Sarah McEwen
Lead, Clinical Science
Tanweer Khan
Senior Director, Head Of Disco...
View all